Partners
Partners

Partner 4 - The University of Manchester


Caroline Dive University of Manchester

Prof. Caroline Dive

 

Principal Investigator

 

Phone: +44 (0)161 446 3036

undefinedE-Mail

 

The University of Manchester

Cancer Research UK Manchester Institute

 

Wilmslow Road

Manchester M20 4BX

United Kingdom

undefinedWebsite

CANCER-ID Team Manchester

Ged Brady Fiona Blackhall

Dr. Ged Brady

 

Deputy Group Leader

 

Development and application of innovative technologies for the molecular analysis of CTCs and cfDNA

 

undefinedE-Mail

 

 

Dr. Fiona Blackhall

 

Honorary Consultant in Medical Oncology at the Christie NHS Foundation Trust & Senior Clinical Lecturer in Oncology at the University of Manchester

 

undefinedE-Mail

Phil Crosbie Richard Booton

Dr. Phil Crosbie

 

Honorary Consultant in Medical Oncology at the Christie    NHS Foundation Trust & Clinical Lecturer in Oncology at the University of Manchester

 

undefinedE-Mail

 

 

Dr. Richard Booton

 

Honorary Clinical Senior Lecturer

 

undefinedE-Mail

Matt Krebs Rajesh Shah

Dr. Matt Krebs

 

Honorary Consultant in Medical Oncology at the Christie    NHS Foundation Trust & Senior Clinical Lecturer in Oncology at the University of Manchester

 

undefinedE-Mail

Dr. Rajesh Shah

 

Consultant in Cardiothoracic Surgeon and Honorary Senior Lecturer

 

undefinedE-Mail

Institute presentation

The Cancer Research UK Manchester Institute is a world leading cancer research institute within The University of Manchester, core funded by Cancer Research UK (CRUK), the largest independent cancer research organisation in the world. We are a partner in the CRUK Centre of Excellence for Lung Cancer and are a key part of the Belfast-Manchester Movember Centre of Excellence for Prostate Cancer.

Our strong links with The Christie NHS Foundation Trust (Western Europe’s largest specialist cancer hospital with the world’s largest early phase clinical trials unit) mean we are ideally placed to maximise interactions between basic and clinical research teams and facilitate rapid translation of fundamental research findings into patient benefit. We sit at the heart of the Manchester Cancer Research Centre (MCRC) partnership, allowing access to human tissue through the Biobank.

Research programs span the whole spectrum of cancer research from the study of the molecular and cellular basis of cancer, to translational research and the development of therapeutics.  We support investigations into a range of cancers, including melanoma, lung cancer, prostate cancer, breast cancer and leukaemia.

Outstanding core facilities at the cutting edge of technology support all research activities, including access to next generation sequencing, expression array analysis, mass-spectrometry, Biological Resource Unit, histopathology, advanced imaging, flow cytometry, bioinformatics and basic laboratory services.  Facilities were further strengthened in 2012 by £8.7m of investment from UKRPIF plus £1.5m from other sources, providing over £10m for the purchase of new specialised equipment.

The Institute offers a stimulating scientific environment that encourages innovative, cross-disciplinary collaboration. We have an excellent track record in the provision of comprehensive PhD training programmes for clinical fellows and postgraduate scientists alike, as well as supporting our young researchers and encouraging them to become future leaders in their field.

CANCER-ID Consortium

CANCER-ID consortium

CANCER-ID Workpackages

CANCER-ID Work Plan

EUROPA - NEWS

News from the European Comission

What's new in Health and Life Sciences? Click here for news from the European Commission.

Search
Top
Home
Menu

EU logo
imi Logo
efpia Logo

News Section

developed by TATAA Biocenter and the Institute of Biotechnology, BIOCEV. Read more

Social Media

LinkedIn Cancer-ID